In re Generic Pharmaceuticals Pricing Antitrust Litigation alleged major generic makers fixed prices on drugs like amoxicillin and gabapentin. Three end-payer settlements (Sandoz/Fougera $275M, Sun/Taro $200M, Apotex/Heritage $58M) pay together on a single claim; the court has granted final approval. Payments are pro rata based on what you spent on the named generic drugs.
Deadline: November 9, 2026 | Payout: pro rata share (varies by documented spend) | Who qualifies: anyone except IN/OH residents who paid out of pocket for named generic drugs May 1, 2009–Dec 31, 2019 (Medicaid excluded) | File: GenericDrugsEndPayerSettlement.com
Useful?